GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,885,721 | -18.6% | 761,419 | +18.1% | 0.00% | 0.0% |
| Q2 2023 | $3,543,387 | +51.2% | 644,500 | +18.3% | 0.00% | 0.0% |
| Q1 2023 | $2,342,977 | +131676.0% | 544,835 | +20.4% | 0.00% | 0.0% |
| Q4 2022 | $1,778 | -99.9% | 452,460 | +35.9% | 0.00% | 0.0% |
| Q3 2022 | $1,768,000 | +110.0% | 332,973 | +159.8% | 0.00% | – |
| Q2 2022 | $842,000 | -8.0% | 128,141 | +2.7% | 0.00% | – |
| Q1 2022 | $915,000 | -2.1% | 124,736 | -5.6% | 0.00% | – |
| Q4 2021 | $935,000 | -36.6% | 132,128 | +124.5% | 0.00% | – |
| Q3 2021 | $1,475,000 | – | 58,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |